Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-25-003535
Filing Date
2025-08-12
Accepted
2025-08-12 18:00:17
Documents
1
Period of Report
2025-08-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 12125
  Complete submission text file 0000902664-25-003535.txt   14301
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017
Business Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017 2124181881
Rubric Capital Management LP (Reporting) CIK: 0001687509 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33221 | Film No.: 251208292

Mailing Address 155 EAST 44TH ST., SUITE 1630 NEW YORK NY 10017
Business Address
Rosen David Efraim (Reporting) CIK: 0001898677 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33221 | Film No.: 251208291